Hidradenitis suppurativa in Crohn's disease. A further support to this association

dc.contributor.authorTsianos, E. V.en
dc.contributor.authorDalekos, G. N.en
dc.contributor.authorTzermias, C.en
dc.contributor.authorMerkouropoulos, M.en
dc.contributor.authorHatzis, J.en
dc.date.accessioned2015-11-24T19:13:53Z
dc.date.available2015-11-24T19:13:53Z
dc.identifier.issn0192-0790-
dc.identifier.urihttps://olympias.lib.uoi.gr/jspui/handle/123456789/21237
dc.rightsDefault Licence-
dc.subjectAdulten
dc.subjectAnti-Bacterial Agents/therapeutic useen
dc.subjectAzathioprine/therapeutic useen
dc.subjectCrohn Disease/*complications/drug therapyen
dc.subjectDrug Therapy, Combinationen
dc.subjectHidradenitis Suppurativa/drug therapy/*etiologyen
dc.subjectHumansen
dc.subjectIsotretinoin/therapeutic useen
dc.subjectMaleen
dc.subjectMethylprednisolone/therapeutic useen
dc.titleHidradenitis suppurativa in Crohn's disease. A further support to this associationen
heal.abstractA patient with Crohn's disease (CD) subsequently developed the clinical and histological features of hidradenitis suppurative (HS). So far, only five cases with such an association have been reported. Azathioprine (150 mg/d) and methylprednisolone (16 mg/d) for CD combined with isotretinoin (0.7 mg/kg) and periodic administration of antibiotics for HS were used. The treatment was satisfactory, and the patient is now in clinical remission for both diseases.en
heal.accesscampus-
heal.fullTextAvailabilityTRUE-
heal.identifier.secondaryhttp://www.ncbi.nlm.nih.gov/pubmed/7769199-
heal.journalNameJ Clin Gastroenterolen
heal.journalTypepeer-reviewed-
heal.languageen-
heal.publicationDate1995-
heal.recordProviderΠανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικήςel
heal.typejournalArticle-
heal.type.elΆρθρο Περιοδικούel
heal.type.enJournal articleen

Αρχεία

Φάκελος/Πακέτο αδειών

Προβολή: 1 - 1 of 1
Φόρτωση...
Μικρογραφία εικόνας
Ονομα:
license.txt
Μέγεθος:
1.74 KB
Μορφότυπο:
Item-specific license agreed upon to submission
Περιγραφή: